CN102219811B - Ca-4衍生物、其制法及其医药用途 - Google Patents

Ca-4衍生物、其制法及其医药用途 Download PDF

Info

Publication number
CN102219811B
CN102219811B CN 201110093276 CN201110093276A CN102219811B CN 102219811 B CN102219811 B CN 102219811B CN 201110093276 CN201110093276 CN 201110093276 CN 201110093276 A CN201110093276 A CN 201110093276A CN 102219811 B CN102219811 B CN 102219811B
Authority
CN
Grant status
Grant
Patent type
Prior art keywords
methoxy
phenoxy
oxo
β
arh
Prior art date
Application number
CN 201110093276
Other languages
English (en)
Chinese (zh)
Other versions
CN102219811A (zh )
Inventor
徐云根
吴梦茜
屠哲玮
司崇静
何书英
何广卫
孙丽
卞金磊
戴宇驰
Original Assignee
中国药科大学
合肥医工医药有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

CN 201110093276 2011-04-14 2011-04-14 Ca-4衍生物、其制法及其医药用途 CN102219811B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201110093276 CN102219811B (zh) 2011-04-14 2011-04-14 Ca-4衍生物、其制法及其医药用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201110093276 CN102219811B (zh) 2011-04-14 2011-04-14 Ca-4衍生物、其制法及其医药用途

Publications (2)

Publication Number Publication Date
CN102219811A true CN102219811A (zh) 2011-10-19
CN102219811B true CN102219811B (zh) 2013-07-03

Family

ID=44776538

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201110093276 CN102219811B (zh) 2011-04-14 2011-04-14 Ca-4衍生物、其制法及其医药用途

Country Status (1)

Country Link
CN (1) CN102219811B (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103288605B (zh) * 2013-06-06 2015-04-08 陕西师范大学 考布他丁的合成方法
CN103421057B (zh) * 2013-08-14 2016-03-30 合肥医工医药有限公司 康普瑞汀氨基糖缀合物、其制法及其医药用途
CN104817519B (zh) * 2015-05-11 2016-11-16 中国药科大学 一类ca-4的衍生物、其制法及其医药用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994005682A1 (en) 1992-08-31 1994-03-17 Francesca Pelizzoni Combretastatin derivatives with antitumoral activity and process for the preparation thereof
CN101591369A (zh) 2008-05-30 2009-12-02 徐云根 N-糖基-3-芳基丙烯酰胺衍生物、其制法及其医药用途

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994005682A1 (en) 1992-08-31 1994-03-17 Francesca Pelizzoni Combretastatin derivatives with antitumoral activity and process for the preparation thereof
CN101591369A (zh) 2008-05-30 2009-12-02 徐云根 N-糖基-3-芳基丙烯酰胺衍生物、其制法及其医药用途

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Brown R. T. 等.Synthesis of Water-soluble Sugar Derivatives of Combretastatin A-4.《Journal of the Chemical Society. Perkin transactions. I》.1995,第577-581页.
Pettit, George R.等.Antineoplastic agents. 322. Synthesis of combretastatin A-4 prodrugs.《Anti-Cancer Drug Design》.1995,第10卷第299-309页.
曲峰,等.氢化可的松氨基糖衍生物的合成.《有机化学》.2003,第23卷(第4期),第361-367页.
李林鲜,等.风车子抑素A4及其衍生物的研究进展.《国际药学研究杂志》.2009,第36卷(第1期),第48-53页.

Also Published As

Publication number Publication date Type
CN102219811A (zh) 2011-10-19 application

Similar Documents

Publication Publication Date Title
US20010041674A1 (en) C-glycosides and preparation of thereof as antidiabetic agents
US6552073B1 (en) Compounds and methods of treating cell proliferative diseases
JPH10306024A (ja) 糸球体疾患の予防および治療剤
CN101362718A (zh) 4-(4-苯甲酰氨基苯氧基)-2-(甲基氨甲酰基)吡啶衍生物及其制备方法和用途
Li et al. Synthesis and evaluation of a novel series of heterocyclic oleanolic acid derivatives with anti-osteoclast formation activity
JPH11269140A (ja) 分化誘導剤
JPH10182550A (ja) ヒドロキシ安息香酸誘導体およびそれを有効成分として含有する医薬品
CN101362702A (zh) 大黄素衍生物及其在制备抗癌药物中的应用
CN102079772A (zh) 一类五环三萜-13,28-内酯化合物、其制备方法和用途
CN102702052A (zh) 含有二胺类的新型法尼基硫代水杨酸衍生物、其制备方法及其医药用途
Alam et al. Synthesis and pharmacological evaluation of 2 (3H)-furanones and 2 (3H)-pyrrolones, combining analgesic and anti-inflammatory properties with reduced gastrointestinal toxicity and lipid peroxidation
CN101613393A (zh) 熊果酸衍生物的合成及其在药物制备中的应用
CN102234259A (zh) 含笑内酯衍生物,其药物组合物及其制备方法和用途
CN101037436A (zh) 左旋千金藤啶碱(l-SPD)衍生物、其制备方法和用途
CN101486703A (zh) 一类具有抗肿瘤活性的黄酮化合物、其制备方法及其用途
CN101735100A (zh) 一种塔斯品碱联苯衍生物及其制备方法
CN102050802A (zh) 一种具有抗缺氧药理活性的n-(2-羟乙基)阿魏酰胺硝酸酯衍生物及其制备方法
Shi et al. Anthranilic acid-based diamides derivatives incorporating aryl-isoxazoline pharmacophore as potential anticancer agents: design, synthesis and biological evaluation
CN102659735A (zh) 槲皮素-3-o-酰基酯及其制备方法
CN103145663A (zh) (s)-2-(2,3-二氢苯并呋喃-3-基)乙酸衍生物,其制备方法及其在医药上的应用
US5451606A (en) Anthraquinone compounds useful to treat osteoarticular conditions, pharmaceutical compositions and method of treatment
US20030144287A1 (en) Novel N-[4- (1H-imidazol-1-yl) -2-fluorophenyl ] -3- (trifluoromethyl) -1H-pyrazole-5-carboxamides as factor Xa inhibitors
CN1706851A (zh) 3-羟基-4,3’,4’,5’-四甲氧基联苄磷酸酯盐及其组合物、制备方法和应用
Jiang et al. An expedient route for the practical preparation of optically active (−)-gossypol
CN102532113A (zh) 芳基脲衍生物

Legal Events

Date Code Title Description
C06 Publication
C10 Request of examination as to substance
C14 Granted